SIRPαFc treatment targets human acute myeloid leukemia stem cells

por Galkin, Oleksandr, McLeod, Jessica, Kennedy, James A., Jin, Liqing, Mbong, Nathan, Wong, Mark, Uger, Robert A., Minden, Mark D., Danska, Jayne S., Wang, Jean C.Y.
Publicado no Haematologica (2020)

AGS67E, an Anti-CD37 Monomethyl Auristatin E Antibody–Drug Conjugate as a Potential Therapeutic for B/T-Cell Malignancies and AML: A New Role for CD37 in AML

por Pereira, Daniel S., Guevara, Claudia I., Jin, Liqing, Mbong, Nathan, Verlinsky, Alla, Hsu, Ssucheng J., Aviña, Hector, Karki, Sher, Abad, Joseph D., Yang, Peng, Moon, Sung-Ju, Malik, Faisal, Choi, Michael Y., An, Zili, Morrison, Kendall, Challita-Eid, Pia M., Doñate, Fernando, Joseph, Ingrid B.J., Kipps, Thomas J., Dick, John E., Stover, David R.
Publicado no Mol Cancer Ther (2015)

CC-90009, a novel cereblon E3 ligase modulator, targets acute myeloid leukemia blasts and leukemia stem cells

por Surka, Christine, Jin, Liqing, Mbong, Nathan, Lu, Chin-Chun, Jang, In Sock, Rychak, Emily, Mendy, Derek, Clayton, Thomas, Tindall, Elizabeth, Hsu, Christy, Fontanillo, Celia, Tran, Eileen, Contreras, Adrian, Ng, Stanley W. K., Matyskiela, Mary, Wang, Kai, Chamberlain, Philip, Cathers, Brian, Carmichael, James, Hansen, Joshua, Wang, Jean C. Y., Minden, Mark D., Fan, Jinhong, Pierce, Daniel W., Pourdehnad, Michael, Rolfe, Mark, Lopez-Girona, Antonia, Dick, John E., Lu, Gang
Publicado no Blood (2021)